Recombinant CBG14675 is typically expressed in E. coli with an N-terminal His-tag for affinity purification.
Data aggregated from commercial suppliers .
Predicted: 35.9 kDa
Observed: 31 kDa (SDS-PAGE)
Discrepancies may arise from post-translational modifications or truncations.
Cholesterol Homeostasis: Catalyzes cholesterol oxidation to 25-hydroxycholesterol (25-HC), a regulator of lipid metabolism .
Immune Modulation: 25-HC induces chemokines like CCL5 in macrophages, linking it to inflammatory responses .
LPS (lipopolysaccharide) upregulates CH25H expression in mice, increasing 25-HC levels and CCL5 secretion .
C. briggsae homolog CBG14675 may share analogous roles in nematode lipid signaling, though in vivo validation is pending .
Recombinant CBG14675 is primarily used in structural and functional studies:
Functional Gaps: No direct evidence of CBG14675’s enzymatic activity or in vivo role in C. briggsae.
Structural Studies: High-resolution crystallography data are lacking.
Therapeutic Potential: Mammalian CH25H is implicated in diabetic kidney disease , suggesting CBG14675 could model related pathways.
KEGG: cbr:CBG14675
STRING: 6238.CBG14675